These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23151457)

  • 1. Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet.
    Triantaphyllidou IE; Kalyvioti E; Karavia E; Lilis I; Kypreos KE; Papachristou DJ
    Osteoarthritis Cartilage; 2013 Feb; 21(2):322-30. PubMed ID: 23151457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
    Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Natural LCAT Mutations on the Biogenesis of HDL.
    Fotakis P; Kuivenhoven JA; Dafnis E; Kardassis D; Zannis VI
    Biochemistry; 2015 Jun; 54(21):3348-59. PubMed ID: 25948084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
    Kypreos KE; Zannis VI
    Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
    Ng DS
    Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
    Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
    Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osbpl8 deficiency in mouse causes an elevation of high-density lipoproteins and gender-specific alterations of lipid metabolism.
    Béaslas O; Metso J; Nissilä E; Laurila PP; Kaiharju E; Batchu KC; Kaipiainen L; Mäyränpää MI; Yan D; Gylling H; Jauhiainen M; Olkkonen VM
    PLoS One; 2013; 8(3):e58856. PubMed ID: 23554939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice.
    Karavia EA; Papachristou DJ; Kotsikogianni I; Triantafyllidou IE; Kypreos KE
    J Nutr Biochem; 2013 Mar; 24(3):567-77. PubMed ID: 22819565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo.
    Tomimoto S; Tsujita M; Okazaki M; Usui S; Tada T; Fukutomi T; Ito S; Itoh M; Yokoyama S
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):394-400. PubMed ID: 11231919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency.
    Chroni A; Duka A; Kan HY; Liu T; Zannis VI
    Biochemistry; 2005 Nov; 44(43):14353-66. PubMed ID: 16245952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein X Causes Renal Disease in LCAT Deficiency.
    Ossoli A; Neufeld EB; Thacker SG; Vaisman B; Pryor M; Freeman LA; Brantner CA; Baranova I; Francone NO; Demosky SJ; Vitali C; Locatelli M; Abbate M; Zoja C; Franceschini G; Calabresi L; Remaley AT
    PLoS One; 2016; 11(2):e0150083. PubMed ID: 26919698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High hydrostatic pressure extract of garlic increases the HDL cholesterol level via up-regulation of apolipoprotein A-I gene expression in rats fed a high-fat diet.
    Lee S; Joo H; Kim CT; Kim IH; Kim Y
    Lipids Health Dis; 2012 Jun; 11():77. PubMed ID: 22713542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice.
    Stukas S; Freeman L; Lee M; Wilkinson A; Ossoli A; Vaisman B; Demosky S; Chan J; Hirsch-Reinshagen V; Remaley AT; Wellington CL
    J Lipid Res; 2014 Aug; 55(8):1721-9. PubMed ID: 24950691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice.
    Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI
    Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency.
    Ossoli A; Strazzella A; Rottoli D; Zanchi C; Locatelli M; Zoja C; Simonelli S; Veglia F; Barbaras R; Tupin C; Dasseux JL; Calabresi L
    Metabolism; 2021 Mar; 116():154464. PubMed ID: 33309714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.